Evidence map›Paper›PMID 29178821›Full record

ReviewAnnual review of genetics2017

Mosaicism in Cutaneous Disorders.

Young H Lim, Zoe Moscato, Keith A Choate

Open access · bronzeAbstract readReview
In one paragraph

Review in Annual review of genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. How Efforts to Understand Somatic Mosaicism Will Impact Dermatology.The Journal of investigative dermatology · 2024
    Article
  9. Article
  10. Mosaicism in Human Health and Disease.Annual review of genetics · 2020
    Review
  11. Mutations in KRT10 in epidermolytic acanthoma.Journal of cutaneous pathology · 2020
    Article
  12. Disorders Caused by Genetic Mosaicism.Deutsches Arzteblatt international · 2020
    Review
  13. Article
  14. Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Young H LimDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520, USA; email: keith.choate@yale.edu.
Zoe MoscatoDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520, USA; email: keith.choate@yale.edu.
Keith A ChoateDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520, USA; email: keith.choate@yale.edu.
Yale University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Mechanisms of Revertant Mosaicism in Ichthyosis with ConfettiR01AR062111 · NIAMS · YALE UNIVERSITY · PI CHOATE, KEITH A · 2011 to 2023
$4.3M
Genetics and Pathobiology of Cutaneous Mosaic DisordersR01AR071491 · NIAMS · YALE UNIVERSITY · PI KEITH A CHOATE · 2018 to 2026
$4.2M
Genetics and pathobiology of ichthyosis en confettiK08AR056305 · NIAMS · YALE UNIVERSITY · PI CHOATE, KEITH A · 2008 to 2012
$647k
NIAMS NIH HHS K08 AR056305NIAMS NIH HHS R01 AR062111NIAMS NIH HHS R01 AR071491NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

Genetic mosaicism arises when a zygote harbors two or more distinct genotypes, typically due to de novo, somatic mutation during embryogenesis. The clinical manifestations largely depend on the differentiation status of the mutated cell; earlier mutations target pluripotent cells and generate more widespread disease affecting multiple organ systems. If gonadal tissue is spared-as in somatic genomic mosaicism-the mutation and its effects are limited to the proband, whereas mosaicism also affecting the gametes, such as germline or gonosomal mosaicism, is transmissible. Mosaicism is easily appreciated in cutaneous disorders, as phenotypically distinct mutant cells often give rise to lesions in patterns determined by the affected cell type. Genetic investigation of cutaneous mosaic disorders has identified pathways central to disease pathogenesis, revealing novel therapeutic targets. In this review, we discuss examples of cutaneous mosaicism, approaches to gene discovery in these disorders, and insights into molecular pathobiology that have potential for clinical translation.

Indexed as

Gene Expression Regulation, DevelopmentalMosaicismMutationEctodermEmbryo, MammalianEndodermExome SequencingHumansKeratin-1Keratin-10Laser Capture MicrodissectionMesodermProto-Oncogene Proteins p21(ras)Receptor, Fibroblast Growth Factor, Type 1Skin Diseases, GeneticTime FactorsFGFR1 protein, humanKeratin-1Keratin-10KRT10 protein, humanKRT1 protein, humanProto-Oncogene Proteins p21(ras)Receptor, Fibroblast Growth Factor, Type 1epigenetic mosaicismlines of Blaschkononsegmental mosaicismRASopathyrevertant mosaicismsegmental mosaicismsomatic mutation

Identifiers

PMID29178821
PMCPMC8026264
OpenAlexW2611812433

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.